in order to assess the androgenic activity of synthetic `` '' progestins '' '' currently used as `` '' antiandrogens '' '' for the treatment of prostate cancer in men , the effect of a series of these compounds has been measured following 14 days of treatment of adult castrated rats on specific and sensitive parameters of androgenic activity , namely ventral prostate weight and prostatic ornithine decarboxylase ( odc ) activity .
C0376358
for
C0033572
and prost